PRO_SELECT: Combining Structure-Based Drug Design and Array-Based Chemistry for Rapid Lead Discovery. 2. The Development of a Series of Highly Potent and Selective Factor Xa Inhibitors
Liebeschuetz, John W, Jones, Stuart D, Morgan, Phillip J, Murray, Chris W, Rimmer, Andrew D, Roscoe, Jonathan M. E, Waszkowycz, Bohdan, Welsh, Pauline M, Wylie, William A, Young, Stephen C, Martin, Harry, Mahler, Jacqui, Brady, Leo, Wilkinson, Kay
Published in Journal of medicinal chemistry (14.03.2002)
Published in Journal of medicinal chemistry (14.03.2002)
Get full text
Journal Article
Abstract 3640: Discovery of quinazolinones as fibroblast growth factor receptor (FGFR1-4) kinase inhibitors
Querolle, Olivier, Angibaud, Patrick, Colombel, Hélène, Caron, Virginie, Pilatte, Isabelle, Poncelet, Virginie, Esser, Norbert, Gilissen, Ron, King, Peter, Meerpoel, Lieven, Verhulst, Tinne, Wroblowski, Berthold, Vialard, Jorge, Murray, Chris W., Rees, David C., Reningovolo, Anita, Saxty, Gordon
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract B154: Characterization of a novel ERK1/2 inhibitor, which modulates the phosphorylation and catalytic activity of ERK1/2
Munck, Joanne M., Berdini, Valerio, Bevan, Luke D., Braithwaite, Hannah, Buck, Ildiko M., Cassidy, Megan, Castro, Juan, Courtin, Aurelie, Day, James E., East, Charlotte, Fazal, Lynsey, Graham, Brent, Griffiths-Jones, Charlotte M., Heightman, Tom D., Hindley, Chris J., Kidane, Birikiti, Kucia-Tran, Justyna, Lyons, John F., Martins, Vanessa, Muench, Sandra, Murray, Chris W., Norton, David, O'Reilly, Marc, Palmer, Nick, Pathuri, Puja, Reader, Mike, Rees, David C., Rich, Sharna J., Richardson, Caroline J., Saini, Harpreet K., Shah, Alpesh, Stanczuk, Lukas, Thompson, Neil T., Walton, Hugh, Wilsher, Nicola E., Woolford, Alison J., Wallis, Nicola G.
Published in Molecular cancer therapeutics (01.01.2018)
Published in Molecular cancer therapeutics (01.01.2018)
Get full text
Journal Article